These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22796793)

  • 1. Commensal-innate immune miscommunication in IBD pathogenesis.
    Cario E
    Dig Dis; 2012; 30(4):334-40. PubMed ID: 22796793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal mucus barrier in normal and inflamed colon.
    Corazziari ES
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S54-5. PubMed ID: 19300126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction.
    Cario E
    Curr Opin Gastroenterol; 2008 Nov; 24(6):725-32. PubMed ID: 19122523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-bacteria interaction in inflammatory bowel disease.
    Knight P; Campbell BJ; Rhodes JM
    Br Med Bull; 2008; 88(1):95-113. PubMed ID: 18931057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.
    Cucchiara S; Stronati L; Aloi M
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S64-6. PubMed ID: 22955361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
    Elson CO; Cong Y; McCracken VJ; Dimmitt RA; Lorenz RG; Weaver CT
    Immunol Rev; 2005 Aug; 206():260-76. PubMed ID: 16048554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.
    Clavel T; Haller D
    Curr Issues Intest Microbiol; 2007 Sep; 8(2):25-43. PubMed ID: 17542334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
    Hörmannsperger G; Haller D
    Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome and immunological interactions.
    Kelly D; Mulder IE
    Nutr Rev; 2012 Aug; 70 Suppl 1():S18-30. PubMed ID: 22861803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation.
    Cader MZ; Kaser A
    Gut; 2013 Nov; 62(11):1653-64. PubMed ID: 24104886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microbiota in inflammatory bowel disease: friend of foe?
    Fava F; Danese S
    World J Gastroenterol; 2011 Feb; 17(5):557-66. PubMed ID: 21350704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
    van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial modulation of mucosal innate immunity.
    Kelly D; Conway S
    Mol Immunol; 2005 May; 42(8):895-901. PubMed ID: 15829279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.
    Kanauchi O; Andoh A; Mitsuyama K
    J Agric Food Chem; 2013 Oct; 61(42):9977-83. PubMed ID: 24070265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal epithelial cells as mediators of the commensal-host immune crosstalk.
    Goto Y; Ivanov II
    Immunol Cell Biol; 2013 Mar; 91(3):204-14. PubMed ID: 23318659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.